Copyright Reports & Markets. All rights reserved.

Global Nicotinamide adenine dinucleotide (NAD+) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Nicotinamide adenine dinucleotide (NAD+) Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Purity＞98%
    • 1.3.3 Purity≤98%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Nicotinamide adenine dinucleotide (NAD+) Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Health Care Products
    • 1.4.3 Beauty Products
    • 1.4.4 Others
  • 1.5 Global Nicotinamide adenine dinucleotide (NAD+) Market Size & Forecast
    • 1.5.1 Global Nicotinamide adenine dinucleotide (NAD+) Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Nicotinamide adenine dinucleotide (NAD+) Sales Quantity (2019-2030)
    • 1.5.3 Global Nicotinamide adenine dinucleotide (NAD+) Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Chromadex
    • 2.1.1 Chromadex Details
    • 2.1.2 Chromadex Major Business
    • 2.1.3 Chromadex Nicotinamide adenine dinucleotide (NAD+) Product and Services
    • 2.1.4 Chromadex Nicotinamide adenine dinucleotide (NAD+) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Chromadex Recent Developments/Updates
  • 2.2 Kingdomway
    • 2.2.1 Kingdomway Details
    • 2.2.2 Kingdomway Major Business
    • 2.2.3 Kingdomway Nicotinamide adenine dinucleotide (NAD+) Product and Services
    • 2.2.4 Kingdomway Nicotinamide adenine dinucleotide (NAD+) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Kingdomway Recent Developments/Updates
  • 2.3 GeneHarbor
    • 2.3.1 GeneHarbor Details
    • 2.3.2 GeneHarbor Major Business
    • 2.3.3 GeneHarbor Nicotinamide adenine dinucleotide (NAD+) Product and Services
    • 2.3.4 GeneHarbor Nicotinamide adenine dinucleotide (NAD+) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 GeneHarbor Recent Developments/Updates
  • 2.4 CELFULL
    • 2.4.1 CELFULL Details
    • 2.4.2 CELFULL Major Business
    • 2.4.3 CELFULL Nicotinamide adenine dinucleotide (NAD+) Product and Services
    • 2.4.4 CELFULL Nicotinamide adenine dinucleotide (NAD+) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 CELFULL Recent Developments/Updates
  • 2.5 MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical)
    • 2.5.1 MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) Details
    • 2.5.2 MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) Major Business
    • 2.5.3 MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) Nicotinamide adenine dinucleotide (NAD+) Product and Services
    • 2.5.4 MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) Nicotinamide adenine dinucleotide (NAD+) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) Recent Developments/Updates
  • 2.6 Bontac
    • 2.6.1 Bontac Details
    • 2.6.2 Bontac Major Business
    • 2.6.3 Bontac Nicotinamide adenine dinucleotide (NAD+) Product and Services
    • 2.6.4 Bontac Nicotinamide adenine dinucleotide (NAD+) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Bontac Recent Developments/Updates
  • 2.7 Herbalmax
    • 2.7.1 Herbalmax Details
    • 2.7.2 Herbalmax Major Business
    • 2.7.3 Herbalmax Nicotinamide adenine dinucleotide (NAD+) Product and Services
    • 2.7.4 Herbalmax Nicotinamide adenine dinucleotide (NAD+) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Herbalmax Recent Developments/Updates
  • 2.8 Maac10 Formulas
    • 2.8.1 Maac10 Formulas Details
    • 2.8.2 Maac10 Formulas Major Business
    • 2.8.3 Maac10 Formulas Nicotinamide adenine dinucleotide (NAD+) Product and Services
    • 2.8.4 Maac10 Formulas Nicotinamide adenine dinucleotide (NAD+) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Maac10 Formulas Recent Developments/Updates
  • 2.9 EffePharm
    • 2.9.1 EffePharm Details
    • 2.9.2 EffePharm Major Business
    • 2.9.3 EffePharm Nicotinamide adenine dinucleotide (NAD+) Product and Services
    • 2.9.4 EffePharm Nicotinamide adenine dinucleotide (NAD+) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 EffePharm Recent Developments/Updates
  • 2.10 Elysium Health
    • 2.10.1 Elysium Health Details
    • 2.10.2 Elysium Health Major Business
    • 2.10.3 Elysium Health Nicotinamide adenine dinucleotide (NAD+) Product and Services
    • 2.10.4 Elysium Health Nicotinamide adenine dinucleotide (NAD+) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Elysium Health Recent Developments/Updates
  • 2.11 Genex Formulas
    • 2.11.1 Genex Formulas Details
    • 2.11.2 Genex Formulas Major Business
    • 2.11.3 Genex Formulas Nicotinamide adenine dinucleotide (NAD+) Product and Services
    • 2.11.4 Genex Formulas Nicotinamide adenine dinucleotide (NAD+) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Genex Formulas Recent Developments/Updates
  • 2.12 NOMON Co., Ltd. (Teijin)
    • 2.12.1 NOMON Co., Ltd. (Teijin) Details
    • 2.12.2 NOMON Co., Ltd. (Teijin) Major Business
    • 2.12.3 NOMON Co., Ltd. (Teijin) Nicotinamide adenine dinucleotide (NAD+) Product and Services
    • 2.12.4 NOMON Co., Ltd. (Teijin) Nicotinamide adenine dinucleotide (NAD+) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 NOMON Co., Ltd. (Teijin) Recent Developments/Updates
  • 2.13 EZZ
    • 2.13.1 EZZ Details
    • 2.13.2 EZZ Major Business
    • 2.13.3 EZZ Nicotinamide adenine dinucleotide (NAD+) Product and Services
    • 2.13.4 EZZ Nicotinamide adenine dinucleotide (NAD+) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 EZZ Recent Developments/Updates

3 Competitive Environment: Nicotinamide adenine dinucleotide (NAD+) by Manufacturer

  • 3.1 Global Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Nicotinamide adenine dinucleotide (NAD+) Revenue by Manufacturer (2019-2024)
  • 3.3 Global Nicotinamide adenine dinucleotide (NAD+) Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Nicotinamide adenine dinucleotide (NAD+) by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Nicotinamide adenine dinucleotide (NAD+) Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Nicotinamide adenine dinucleotide (NAD+) Manufacturer Market Share in 2023
  • 3.5 Nicotinamide adenine dinucleotide (NAD+) Market: Overall Company Footprint Analysis
    • 3.5.1 Nicotinamide adenine dinucleotide (NAD+) Market: Region Footprint
    • 3.5.2 Nicotinamide adenine dinucleotide (NAD+) Market: Company Product Type Footprint
    • 3.5.3 Nicotinamide adenine dinucleotide (NAD+) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Nicotinamide adenine dinucleotide (NAD+) Market Size by Region
    • 4.1.1 Global Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Nicotinamide adenine dinucleotide (NAD+) Consumption Value by Region (2019-2030)
    • 4.1.3 Global Nicotinamide adenine dinucleotide (NAD+) Average Price by Region (2019-2030)
  • 4.2 North America Nicotinamide adenine dinucleotide (NAD+) Consumption Value (2019-2030)
  • 4.3 Europe Nicotinamide adenine dinucleotide (NAD+) Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Nicotinamide adenine dinucleotide (NAD+) Consumption Value (2019-2030)
  • 4.5 South America Nicotinamide adenine dinucleotide (NAD+) Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Nicotinamide adenine dinucleotide (NAD+) Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Type (2019-2030)
  • 5.2 Global Nicotinamide adenine dinucleotide (NAD+) Consumption Value by Type (2019-2030)
  • 5.3 Global Nicotinamide adenine dinucleotide (NAD+) Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Application (2019-2030)
  • 6.2 Global Nicotinamide adenine dinucleotide (NAD+) Consumption Value by Application (2019-2030)
  • 6.3 Global Nicotinamide adenine dinucleotide (NAD+) Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Type (2019-2030)
  • 7.2 North America Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Application (2019-2030)
  • 7.3 North America Nicotinamide adenine dinucleotide (NAD+) Market Size by Country
    • 7.3.1 North America Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Nicotinamide adenine dinucleotide (NAD+) Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Type (2019-2030)
  • 8.2 Europe Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Application (2019-2030)
  • 8.3 Europe Nicotinamide adenine dinucleotide (NAD+) Market Size by Country
    • 8.3.1 Europe Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Nicotinamide adenine dinucleotide (NAD+) Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Nicotinamide adenine dinucleotide (NAD+) Market Size by Region
    • 9.3.1 Asia-Pacific Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Nicotinamide adenine dinucleotide (NAD+) Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Type (2019-2030)
  • 10.2 South America Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Application (2019-2030)
  • 10.3 South America Nicotinamide adenine dinucleotide (NAD+) Market Size by Country
    • 10.3.1 South America Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Nicotinamide adenine dinucleotide (NAD+) Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Nicotinamide adenine dinucleotide (NAD+) Market Size by Country
    • 11.3.1 Middle East & Africa Nicotinamide adenine dinucleotide (NAD+) Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Nicotinamide adenine dinucleotide (NAD+) Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Nicotinamide adenine dinucleotide (NAD+) Market Drivers
  • 12.2 Nicotinamide adenine dinucleotide (NAD+) Market Restraints
  • 12.3 Nicotinamide adenine dinucleotide (NAD+) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Nicotinamide adenine dinucleotide (NAD+) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Nicotinamide adenine dinucleotide (NAD+)
  • 13.3 Nicotinamide adenine dinucleotide (NAD+) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Nicotinamide adenine dinucleotide (NAD+) Typical Distributors
  • 14.3 Nicotinamide adenine dinucleotide (NAD+) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in all living cells and is involved in numerous metabolic reactions. It plays a crucial role in cellular energy production, particularly in the processes of glycolysis, the citric acid cycle (Krebs cycle), and oxidative phosphorylation. NAD+ functions as a cofactor for enzymes involved in these metabolic pathways, helping to transfer electrons and protons during the oxidation-reduction reactions that generate energy in the form of ATP (adenosine triphosphate).
    According to our (Global Info Research) latest study, the global Nicotinamide adenine dinucleotide (NAD+) market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Nicotinamide adenine dinucleotide (NAD+) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Nicotinamide adenine dinucleotide (NAD+) market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2019-2030
    Global Nicotinamide adenine dinucleotide (NAD+) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2019-2030
    Global Nicotinamide adenine dinucleotide (NAD+) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2019-2030
    Global Nicotinamide adenine dinucleotide (NAD+) market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Nicotinamide adenine dinucleotide (NAD+)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Nicotinamide adenine dinucleotide (NAD+) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chromadex, Kingdomway, GeneHarbor, CELFULL, MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical), Bontac, Herbalmax, Maac10 Formulas, EffePharm, Elysium Health, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Nicotinamide adenine dinucleotide (NAD+) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity＞98%
    Purity≤98%
    Market segment by Application
    Health Care Products
    Beauty Products
    Others
    Major players covered
    Chromadex
    Kingdomway
    GeneHarbor
    CELFULL
    MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical)
    Bontac
    Herbalmax
    Maac10 Formulas
    EffePharm
    Elysium Health
    Genex Formulas
    NOMON Co., Ltd. (Teijin)
    EZZ
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Nicotinamide adenine dinucleotide (NAD+) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Nicotinamide adenine dinucleotide (NAD+), with price, sales quantity, revenue, and global market share of Nicotinamide adenine dinucleotide (NAD+) from 2019 to 2024.
    Chapter 3, the Nicotinamide adenine dinucleotide (NAD+) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Nicotinamide adenine dinucleotide (NAD+) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Nicotinamide adenine dinucleotide (NAD+) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Nicotinamide adenine dinucleotide (NAD+).
    Chapter 14 and 15, to describe Nicotinamide adenine dinucleotide (NAD+) sales channel, distributors, customers, research findings and conclusion.

    Buy now